Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Nimish Maheshwari, an independent analyst and co-founder of Beat The Street, is an investing platform garnering more than 1,00,000+ followers across social media. 
His deep insights and forensic analysis have been featured in some of India's most prominent publications, including the Economic Times, The Morning Context, The Ken,  Dalal Street Investment Journal, Moneylife by Sucheta Dalal, and TheCore.in.
He has a keen eye for identifying red flags in Indian listed companies and has identified exclusive red flags earlier in Adani, Vedanta, Nykaa, Gland Pharma, Brightcom Group etc.

Market & Forensics Analyst

Indian E-Bus Market: Players, Competition, Orders & Business Model

Korea's Possible Citizen/National Dividend Policy: KOSPI & Samsung Falls!

Is Nuclear Becoming Strategic Infrastructure Again?

How Waaree Energies(The Moat Builder) Is Wiring Together India's Entire Solar Stack?

Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

Vedanta Post-Demerger: Is It Worth Holding?

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Thematic (Sector/Industry)

China Materials / Thematic (Sector/Industry)

<ul>
<li>China's Politburo formalized "anti-involution" policy in July 2024, escalating through 2025 to mandate capacity cuts, retire aging petrochemical plants, and penalize destructive price competition in chemicals and beyond.</li>
<li>China accounts for roughly 46% of global chemical production. Structural capacity rationalization there directly shifts pricing power, trade flows, and market share for Indian chemical players competing on cost, complexity.</li>
<li>Companies with complex chemistry moats, low Chinese raw-material dependence, and long-term customer contracts stand to gain most; commodity-adjacent players face a more uneven ride. </li>
</ul>


China's Politburo formalized "anti-involution" policy in July 2024, escalating through 2025 to mandate capacity cuts, retire aging petrochemical plants, and penalize destructive price competition in chemicals and beyond.
China accounts for roughly 46% of global chemical production. Structural capacity rationalization there directly shifts pricing power, trade flows, and market share for Indian chemical players competing on cost, complexity.
Companies with complex chemistry moats, low Chinese raw-material dependence, and long-term customer contracts stand to gain most; commodity-adjacent players face a more uneven ride. 


What China's Anti-Involution Drive Means for India's Chemical Sector?